|Sponsored by the HealthcareTrainingInstitute.org providing Quality Education since 1979|
If you would like additional information on this topic,
- Bartlett, John G., M.D. and Finkbeiner, Ann K.; "The Guide to Living with HIV Infection, Fifth Edition." The John Hopkins University Press. Baltimore, MD. 2001.
- Britton, Paula; Staying on the Roller Coaster with Clients: Implications of the New HIV/AIDS Medical Treatments for Counseling; Journal of Mental Health Counseling; Jan 2000; Vol. 22 Issue 1
- Cartwright, Duncan, and Michael Cassidy; Working with HIV/AIDS Sufferers: "When Good Enough Is Not Enough"; American Journal of Psychotherapy; Spring 2002; Vol. 56 Issue 2
- Gadkowski, L. Beth; Hamilton, Carol D.; Allen, Myra; Fortenberry, Ellen R.; Luffman, Julie; Zeringue, Elizabeth; Stout, Jason E; HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons; AIDS Patient Care & STDs, November 2009, Vol 23 Issue 10, p845
- Grodek, Brett; "HIV: The First Year, An Essential Guide for the Newly Diagnosed." Malowe and Company. New York, NY. 2003.
- Health Reources and Services Administration, HIV/AIDS Bureau. (2015). HIV/AIDS Bureau Division of Policy and Data Consultation Overview. U.S. Department of Health and Human Services.
- Hosek, Sybil, Gary Harper, and Rocco Domanico; Psychological and Social Difficulties of Adolescents Living With HIV: A Qualitative Analysis; Journal of Sex Education & Therapy; 2000; Vol. 25 Issue 4
- Hunt, Brandon, Jodi Jaques, Spencer Niles, and Edward Wierzalis; Career Concerns for People Living with HIV/AIDS; Journal of Counseling & Development; Winter 2003; Vol. 81 Issue 1
- Kaiser, Jon D., M.D.; "Immune Power: A Comprehensive Treatment Program for HIV." St. Martin’s Press. New York, NY. 1993.
- Lombard, Frank; Proescholdbell, Rae Jean; Cooper, Katherine; Musselwhite, Laura; Quinlivan, Evelyn Byrd; Adaptations across Clinical Sites of an Integrated Treatment Model for Persons with HIV and Substance Abuse; AIDS Patient Care & STDs, August 2009, Vol 23 Issue 8, p631
- Serovich, JM, PS Brucker, and JA Kimberly; Barriers to social support for persons living with HIV/AIDS; AIDS Care; Oct 2000; Vol. 12 Issue 5
- Sohler, Nancy L.; Xuan Li; Cunningham, Chinazo O.; Gender Disparities in HIV Health Care Utilization among the Severely Disadvantaged: Can We Determine the Reasons?; AIDS Patient Care & STDs, September 2009, Vol 23 Issue 9, p775
- Springer, Carrie and Suzanne Lease; The Impact of Multiple AIDS-Related Bereavement in the Gay Male Population; Journal of Counseling & Development; Summer 2000; Vol. 78 Issue 3
- Talbot, Annie; Uwihoreye, Chaste; Kamen, Charles; Grant, Philip; McGlynn, Lawrence; Mugabe, Isaac; Nshimyumukiza, Martin; Dongier, Pierre; Slamowitz, Debbie; Padilla, Cindy; Uvamahoro, Jaqueline; Musayidire, Irene; Mukarubuga, Ancilla; Zolopa, Andrew. "Treating Psychological Trauma Among Rwandan Orphans Is Associated With a Reduction in HIV Risk-Taking Behaviors: A Pilot Study." AIDS Education & Prevention. Dec2013, Vol. 25 Issue 6, p468-479. 12p. 4 Charts, 2 Graphs. DOI: 10.1521/aeap.2013.25.6.468.
- Waugh, Amy; Austin, Allana; Manthorpe, Jill; Fox, Chris; Stephens, Barbara; Robinson, Louise; Iliffe, Steve. "Designing a complex intervention for dementia case management in primary care." BMC Family Practice. 2013, Vol. 14 Issue 1, p101-111. 11p. 1 Diagram, 4 Charts. DOI: 10.1186/1471-2296-14-101.
- Zinck, Kirk E.; Cutcliffe, John R. "Hope Inspiration among People Living with HIV/AIDS: Theory and Implications for Counselors." Journal of Mental Health Counseling. Jan2013, Vol. 35 Issue 1, p60-75. 16p. 3 Charts.
Others who bought this HIV/AIDS Course
Test for this course | HIV/AIDS CEU Courses
Forward to Section 14
Back to Section 12
Table of Contents
The integrase inhibitors dolutegravir (Tivicay, also in Triumeq and Dovato) and raltegravir (Isentress) cause changes in the structure of fat cells that may promote obesity, and can cause insulin resistance, studies of cells sampled from people living with HIV and monkeys exposed to the drugs have found. The findings were presented last week at the 17th European AIDS Conference (EACS 2019) in Basel, Switzerland.
People with suppressed viral load who switched to an integrase inhibitor-based regimen experienced only small gains in weight and do not appear to gain more weight than HIV-negative people or people who continued taking other regimens, two large cohort studies presented at the 17th European AIDS Conference (EACS 2019) reported.
PREVENIR, the French open-label study looking at PrEP use in gay and bisexual men in the Paris region, has found that 16% of study participants either told clinicians they were stopping PrEP or disappeared from the study within a year, and that 32% had discontinued PrEP after 30 months. Younger men (aged 25 and under), people who had never taken PrEP before and men with poorer education were all more likely to discontinue PrEP than other men in the study.
The tenth edition of the European AIDS Clinical Society Guidelines was launched at the society's 17th European AIDS Conference (EACS 2019), in Basel, Switzerland last Thursday. Its expansion in size – from 109 pages in the ninth print edition first published two years ago to 283 pages today, plus numerous online-only supplementary tables – is evidence of the complexity of needs it seeks to address.
An Australian study of gay men recruited in community settings in Sydney, Australia has found a very high prevalence of HSIL (high-grade squamous intraepithelial lesions – precancerous changes in the cells of the anal lining that may indicate a risk of developing cancer). Yet in three years of follow-up, only one man out of 617 progressed to anal cancer, the 17th European AIDS Conference (EACS 2019) in Basel, Switzerland heard.